# Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/molecular-subtyping-and-genomic-profiling-expand-precision-medicine-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yi-Zhou Jiang,Yin Liu,Yi Xiao,Xin Hu,Lin Jiang,Wen-Jia Zuo,Ding Ma,Jia-Han Ding,Xiaoyu Zhu,Jianjun Zou,Claire F. Verschraegen,Daniel G. Stover,Virginia Kaklamani,Zhong-Hua Wang,Zhi‐Ming Shao |
| Citations | 316 |
| DOI | 10.1038/s41422-020-0375-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41422-020-0375-9.pdf |
| OpenAlex ID | https://openalex.org/W3044428842 |
| PMID | 32719455 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Ding Ma](https://scholariq.org/researchers/ding-ma/)

## Paper primary topic

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Paper topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.